Connect Biopharma Holdings Limited

NasdaqGM:CNTB 주식 보고서

시가총액: US$73.3m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Connect Biopharma Holdings 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Barry Quart

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권n/a
경영진 평균 재임 기간2.6yrs
이사회 평균 재임 기간3.4yrs

최근 관리 업데이트

Recent updates

Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Mar 07
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Sep 19
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Mar 29
Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Dec 14
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Market Appears To Relegate Connect Biopharma To A Long-Term Hold

Oct 10

Connect Biopharma Is A Sleeper Heading Into October Data Readout

Sep 26

Connect Biopharma reports 1H results

Sep 13

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Aug 12
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Apr 29
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares

Jan 12

We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Jan 01
We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

CEO

Barry Quart (67 yo)

no data

테뉴어

Dr. Barry D. Quart, Pharm D., serves as Chief Executive Officer & Director of Connect Biopharma Holdings Limited since June 12, 2024. He had served as Chief Executive Officer of Heron Therapeutics, Inc. si...


리더십 팀

이름위치테뉴어보상소유권
Zheng Wei
Co-Founder & Director12.4yrs데이터 없음10.76%
$ 7.9m
Wubin Pan
Co-Founder & Directorno data데이터 없음11.25%
$ 8.2m
Steven Chan
Chief Financial Officer2.6yrs데이터 없음0.014%
$ 10.0k
Barry Quart
CEO & Directorno data데이터 없음데이터 없음
David Szekeres
Presidentno data데이터 없음데이터 없음
Jiang Bian
General Counsel & Chief Compliance Officer2.8yrs데이터 없음데이터 없음
Lei Sun
VP of Biologics & Head of CMC4.4yrs데이터 없음데이터 없음
Raul Collazo
VP & Global Head of Medical Affairsno data데이터 없음데이터 없음
Srikanth Pendyala
Senior Vice President of Clinical Development(Consultant)less than a year데이터 없음데이터 없음

2.6yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 관리: CNTB 의 관리팀은 경험 ( 2.6 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Zheng Wei
Co-Founder & Director12.4yrs데이터 없음10.76%
$ 7.9m
Wubin Pan
Co-Founder & Director12.1yrs데이터 없음11.25%
$ 8.2m
Barry Quart
CEO & Directorno data데이터 없음데이터 없음
Stuart J. Swiedler
Member of Scientific Advisory Board3.4yrs데이터 없음데이터 없음
Jean I. Liu
Independent Director2.8yrs데이터 없음0%
$ 0
Karen Wilson
Independent Non-Executive Director3.5yrs데이터 없음0.018%
$ 13.3k
Kleanthis Xanthopoulos
Independent Chairman3.5yrs데이터 없음0%
$ 0
Brian Gordon Feagan
Member of Scientific Advisory Board3.4yrs데이터 없음데이터 없음
David T. Rubin
Member of Scientific Advisory Board3.4yrs데이터 없음데이터 없음
Emma Guttman-Yassky
Member of Scientific Advisory Board3.4yrs데이터 없음데이터 없음
Kan Chen
Independent Non-Executive Director3.5yrs데이터 없음데이터 없음
Edward M. Kerwin
Member of Scientific Advisory Board3.4yrs데이터 없음데이터 없음

3.4yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 이사회: CNTB 의 이사회경험(평균 재직 기간 3.4 년)으로 간주됩니다.